Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15502314rdf:typepubmed:Citationlld:pubmed
pubmed-article:15502314lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C1419366lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0010423lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0043301lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:15502314lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:15502314pubmed:issuePt 11lld:pubmed
pubmed-article:15502314pubmed:dateCreated2004-10-25lld:pubmed
pubmed-article:15502314pubmed:abstractTextRegucalcin is a novel calcium ion (Ca(2+)) binding protein that does not contain an EF-hand motif as a Ca(2+)-binding domain and has been demonstrated to play a multi-functional role in many cell types. Human liver regucalcin, consisting of 299 amino-acid residues, was overexpressed in Escherichia coli, purified and crystallized by the vapour-diffusion method in the presence of polyethylene glycol 4000 as a precipitant. A native crystal diffracted to 2.8 A with synchrotron radiation and belongs to space group P2(1), with unit-cell parameters a = 64.87, b = 52.52, c = 86.38 A, beta = 99.86 degrees . Two molecules most probably exist in the asymmetric unit, corresponding to V(M) = 2.2 A(3) Da(-1). Heavy-atom derivative data were collected and the Pb derivative showed one high-occupancy site per molecule.lld:pubmed
pubmed-article:15502314pubmed:languageenglld:pubmed
pubmed-article:15502314pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:citationSubsetIMlld:pubmed
pubmed-article:15502314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502314pubmed:statusMEDLINElld:pubmed
pubmed-article:15502314pubmed:monthNovlld:pubmed
pubmed-article:15502314pubmed:issn0907-4449lld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:KinoshitaTaka...lld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:NakajimaHiden...lld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:ShibataTakash...lld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:FujiiTakashiTlld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:SaitoNorikoNlld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:WarizayaMasai...lld:pubmed
pubmed-article:15502314pubmed:authorpubmed-author:YamaokaMakiko...lld:pubmed
pubmed-article:15502314pubmed:issnTypePrintlld:pubmed
pubmed-article:15502314pubmed:volume60lld:pubmed
pubmed-article:15502314pubmed:ownerNLMlld:pubmed
pubmed-article:15502314pubmed:authorsCompleteYlld:pubmed
pubmed-article:15502314pubmed:pagination2019-21lld:pubmed
pubmed-article:15502314pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:meshHeadingpubmed-meshheading:15502314...lld:pubmed
pubmed-article:15502314pubmed:year2004lld:pubmed
pubmed-article:15502314pubmed:articleTitleExpression, purification, crystallization and preliminary X-ray diffraction studies of human liver regucalcin.lld:pubmed
pubmed-article:15502314pubmed:affiliationExploratory Research Laboratory, Fujisawa Pharmaceutical Co. Ltd, 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan. masaichi_warizaya@po.fujisawa.co.jplld:pubmed
pubmed-article:15502314pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:9104entrezgene:pubmedpubmed-article:15502314lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15502314lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15502314lld:pubmed